Skip to main content

Table 2 Characteristics of survey respondents

From: Criteria for site selection in industry-sponsored clinical trials: a survey among decision-makers in biopharmaceutical companies and clinical research organizations

Characteristics

All respondents (n = 83)

Respondents from biopharmaceutical companies (n = 43)

Respondents from clinical research organizations (n = 40)

Type of companya (frequency counts %)

 Large biopharmaceutical company

41 (50)

41 (95)

 Small/medium-sized biopharmaceutical company

2 (2)

2 (5)

 Large CRO

16 (19)

16 (40)

 Small/medium-sized CRO

24 (29)

24 (60)

Position (frequency counts %)

 Clinical operations responsible

48 (58)

35 (81)

13 (33)

 Study manager

13 (16)

5 (12)

8 (20)

 Monitor

22 (26)

3 (7)

19 (47)

Experience (frequency counts %)

 < 2 years

5 (6)

1 (2)

4 (10)

 2–5 years

11 (13)

4 (9)

7 (17)

 > 5 years

67 (81)

38 (89)

29 (73)

  1. a Company size was defined in accordance with the definition by the European Commission: Small/medium-sized = employees < 250 and turnover < 50 million € globally (http://ec.europa.eu/growth/smes/business-friendly-environment/sme-definition_da)